ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 34 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $12,000 | – | 69,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ANGELO GORDON & CO., L.P. | 60,000 | $584,000 | 0.06% |
Empery Asset Management, LP | 39,700 | $6,000 | 0.03% |
Radcliffe Capital Management, L.P. | 80,001 | $779,000 | 0.02% |
Anson Funds Management LP | 15,000 | $146,000 | 0.01% |
Segantii Capital Management Ltd | 30,000 | $292,000 | 0.01% |
Arena Capital Advisors, LLC- CA | 111,314 | $17,000 | 0.00% |
683 Capital Management, LLC | 239,800 | $36,000 | 0.00% |
Atalaya Capital Management LP | 100,000 | $15,000 | 0.00% |
MMCAP International Inc. SPC | 159,802 | $24,000 | 0.00% |
MARSHALL WACE, LLP | 54,995 | $536,000 | 0.00% |